Skip to main content
Premium Trial:

Request an Annual Quote

Nucleome Therapeutics: John Davis, Gerd Blobel, Craig Fox, Steve Holmes, Iain Kilty, Christopher Miller, Sonia Quaratino

UK genomics firm Nucleome Therapeutics has appointed John Davis as a non-executive director and has established a scientific advisory board. Davis was previously head of R&D and chief medical officer at Magenta Therapeutics. Prior to that, he was senior VP and head of early clinical development at Pfizer, VP and global therapeutic area head of immunology at Baxalta, and head of the inflammation and cardiovascular/metabolism group in the early clinical development group at Genentech.

Members of the SAB are Gerd Blobel, codirector of the epigenetics institute at the University of Pennsylvania and codirector of the spatial and functional genomics program at Children's Hospital of Philadelphia; Craig Fox, operating partner in life sciences at Oxford Science Enterprises; Steve Holmes, former CEO of Capella Bioscience; Iain Kilty, CSO of Sitryx Therapeutics; Christopher Miller, founder of Genomics Innovation Consulting; and Sonia Quaratino, executive VP and chief medical officer of Innate Pharma.